Error: Could not add to watchlist. X
+ Watchlist

Mayne Pharma Group Ltd

MYPHY:US
OTC US
Price not available for MYPHY:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-
Market Cap (USD)
-
Shares Outstanding (m)
151.259
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.16%
% Price Change
-0.03%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Mayne Pharma Group Ltd. develops and manufactures oral pharmaceuticals. The Company produces branded generics, specialty generics, and active pharmaceutical ingredients.
Address
1538 Main North Road
Salisbury South, SA 5106
Australia
Phone
61-8-8209-2666
  • Scott Richards
    CEO/Managing Dir/Executive Dir
  • Nick Freeman
    CFO/Secretary
  • Stefan J Cross
    Chief Commercial Officer
  • Peter Paltoglou
    Chief Development Ofcr/Head:EMEA
  • Eric W Evans
    CFO:Mayne Pharma USA
Show More